RecruitingPhase 2ketamine

Ayahuasca, Esketamine and PTSD

Sponsored by University of Sao Paulo

NCT ID
NCT07317206
Target Enrollment
10 participants
Start Date
2025-12-20
Est. Completion
2026-07

About This Study

Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.

Conditions Studied

Posttraumatic Stress Disorder (PTSD)

Interventions

  • •Ayahuasca
  • •Esketamine

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* posttraumatic stress disorder

Exclusion Criteria:

* psychiatric and other medical comorbidities

Study Locations (1)

Hospital das Clínicas da FMRP-USP
Ribeirão Preto, São Paulo, Brazil

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Ayahuasca, Esketamine and PTSD | Huxley